Company Analysis

Genprex, Inc. (GNPX)

Nasdaq: GNPX · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2013
Grade4.3
◀ Past 3.4● Present 3.5▶ Future 5.4
5 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 30, 2026Apr 1, 2025Apr 1, 2024Mar 31, 2023Mar 30, 2022Mar 26, 2021Mar 30, 2020Apr 1, 2019Apr 17, 2018·
Revenue·00000·000
Research and development9,428,72010,535,44617,616,60511,510,0748,970,865r7,302,9231,967,007971,427289,934354,883
General and administrative6,086,89910,632,02813,425,285r12,295,07011,676,703r10,635,8818,702,59611,386,2293,019,1713,776,414
Total costs and expenses15,515,61921,174,16731,056,894r23,830,71920,670,102r17,961,58110,682,67312,363,5413,312,3474,132,159
Operating income-15,515,619-21,174,167-31,056,894r-23,830,719-20,670,102r-17,961,581-10,682,673-12,363,541-3,312,347-4,132,159
Interest expense·······37,9821,8900
Interest and investment income·63,574215,10990,0985,13318,81127,90529,184800
Total non-operating income (expense)·······-8,798-1,8100
Income tax expense02,65000······
Net income including non-controlling interests·······-12,372,339-3,314,157·
Net income-16,228,953-21,111,163-30,860,461-23,740,621-20,664,969r-17,942,770-10,654,768-12,372,339-3,314,157-4,132,159
Net income to common shareholders-16,228,953-21,388,282-30,860,461·······
Earnings per share, basic-17.40-266.89r-1,128.00b-990.00rb-880.00b·····
Earnings per share, basic and diluted····-840.00b-1,020.00b-1,320.00b-1,800.00b-580.00b-760.00b
Weighted average shares, basic932,73080,139r27,355b23,977rb23,549b·····
Weighted average shares, basic and diluted····23,549b17,761b8,013b6,886b5,750b5,417b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-50 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton GNPX · research, not advice